These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23341104)

  • 1. Bioinformatics analysis reveals potential candidate drugs for HCC.
    Huang XB; Li J; Zheng L; Zuo GH; Han KQ; Li HY; Liang P
    Pathol Oncol Res; 2013 Apr; 19(2):251-8. PubMed ID: 23341104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor.
    Nair G; Hema Sree GNS; Saraswathy GR; Marise VLP; Krishna Murthy TP
    Med Oncol; 2021 Oct; 38(12):145. PubMed ID: 34687371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
    Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
    J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.
    Shangguan H; Tan SY; Zhang JR
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2054-61. PubMed ID: 26125269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma.
    Yuan W; Tao R; Huang D; Yan W; Shen G; Ning Q
    Aging (Albany NY); 2021 Jan; 13(3):3969-3993. PubMed ID: 33495404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines.
    Agioutantis PC; Loutrari H; Kolisis FN
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32517019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
    Zhang X; Yin S; Ma K
    J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
    Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
    DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
    Cai C; Song X; Yu C
    Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CXCL8 and CCNB1 in predicting hepatocellular carcinoma in the context of cirrhosis: implications for early detection and immune-based therapies.
    Sun Q; An R; Li J; Liu C; Wang M; Wang C; Wang Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11471-11489. PubMed ID: 37391641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.
    Piccioni F; Fiore E; Bayo J; Atorrasagasti C; Peixoto E; Rizzo M; Malvicini M; Tirado-González I; García MG; Alaniz L; Mazzolini G
    Glycobiology; 2015 Aug; 25(8):825-35. PubMed ID: 25882295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D
    PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.